Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EIF2AK4 | Q9P2K8 | 4/20 | 0.67 |
| ▸ | FLT3 | P36888 | 7/20 | 0.61 |
| ▸ | EGFR | P00533 | 3/20 | 0.61 |
| ▸ | TBK1 | Q9UHD2 | 2/20 | 0.53 |
| ▸ | CDK4 | P11802 | 1/20 | 0.49 |
| ▸ | CCND1 | P24385 | 1/20 | 0.49 |
| ▸ | CCND2 | P30279 | 1/20 | 0.49 |
| ▸ | CCND3 | P30281 | 1/20 | 0.49 |
| ▸ | AURKA | O14965 | 2/20 | 0.49 |
| ▸ | SYK | P43405 | 1/20 | 0.49 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.48 |
| ▸ | XDH | P47989 | 1/20 | 0.47 |
| ▸ | BLK | P51451 | 1/20 | 0.47 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.47 |
| ▸ | JAK2 | O60674 | 1/20 | 0.47 |
| ▸ | PAK4 | O96013 | 1/20 | 0.47 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1356007 | 0.88 | EIF2AK4 (0.67) | EIF2AK4FLT3EGFRTBK1CDK4 | |
| SCHEMBL1355529 | 0.88 | EIF2AK4 (0.53) | EIF2AK4FLT3EGFRTBK1CDK4 | |
| SCHEMBL1356855 | 0.86 | EIF2AK4 (0.64) | EIF2AK4FLT3EGFRTBK1CDK4 | |
| SCHEMBL1356307 | 0.86 | EIF2AK4 (0.61) | EIF2AK4FLT3EGFRTBK1CDK4 | |
| SCHEMBL1353786 | 0.84 | EIF2AK4 (0.62) | EIF2AK4FLT3EGFRTBK1CDK4 | |
| SCHEMBL1356098 | 0.84 | EIF2AK4 (0.62) | EIF2AK4FLT3EGFRTBK1CDK4 | |
| SCHEMBL1355646 | 0.84 | FLT3 (0.64) | EIF2AK4FLT3EGFRTBK1CDK4 | |
| SCHEMBL1355988 | 0.84 | FLT3 (0.64) | EIF2AK4FLT3EGFRTBK1CDK4 | |
| SCHEMBL1355752 | 0.84 | EIF2AK4 (0.62) | EIF2AK4EGFRTBK1CDK4CCND1 | |
| SCHEMBL1353936 | 0.84 | AURKA (0.49) | EIF2AK4FLT3EGFRCDK4CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110281821-A9 | Modulators of Mitotic Kinases | BIOGEN IDEC MA INC. (US) | 2011-11-17 | — | — | US | claimed |
| US-20100249067-A1 | Modulators of Mitotic Kinases | BIOGEN IDEC MA INC. (US) | 2010-09-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249067-A1 | Modulators of Mitotic Kinases | BUB1, BUB1B, CDK1 | EIF2AK4 791/4885FLT3 766/4885EGFR 1291/4885 |
| US-20110281821-A9 | Modulators of Mitotic Kinases | BUB1, BUB1B, CDK1 | EIF2AK4 791/4885FLT3 766/4885EGFR 1291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.